1. Victoria D. Lauenroth was a research associate at the Hamburg Center for Health Economics, in Hamburg, Germany, and a visiting researcher at the Harvard-MIT Center for Regulatory Science, Harvard Medical School, in Boston, Massachusetts, when this work was conducted.
2. Aaron S. Kesselheim is a professor of medicine and the director of the Program on Regulation, Therapeutics, and Law in the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, in Boston.
3. Ameet Sarpatwari is an assistant professor of medicine and the assistant director of the Program on Regulation, Therapeutics, and Law in the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School.
4. Ariel D. Stern () is the Poronui Associate Professor of Business Administration in the Technology and Operations Unit at Harvard Business School and the Harvard-MIT Center for Regulatory Science, both in Boston.